Document is current
Any future updates will be listed below
-
Authors
Wintergerst, Maximilian W. M.
Falahat, Peyman
Holz, Frank G.
Schaefer, Christian
Finger, Robert P.
Schahab, Nadjib
-
Funding
Funding for this research was provided by:
BONFOR GEROK Program, Faculty of Medicine, University of Bonn Grant (O-137.0028)
German Ophthalmic Society
Else Kroener-Fresenius Foundation and the German Scholars Organization (EKFS/GSO 16)
Universitätsklinikum Bonn
- License Information
-
More Information
Article History
Received: 3 January 2021
Accepted: 17 May 2021
First Online: 1 June 2021
Competing interests
: The Department of Ophthalmology, University of Bonn received imaging devices from Heidelberg Engineering, Optos, Carl Zeiss Meditec, and CenterVue. Additional competing interests: Wintergerst MWM: Heine Optotechnik: Grant, personal fees and non-financial support, ASKIN & CO: personal fees and non-financial support, Berlin-Chemie AG: Grant and non-financial support, D-EYE: non-financial support, DigiSight Technologies: non-financial support, Eyenuk: non-financial support; Falahat P: no additional disclosures; Holz FG: Acucela: Grant, personal fees and non-financial support, Allergan: Grant and non-financial support, Appelis: personal fees and non-financial support, Bayer: Grant, personal fees and non-financial support, Boehringer-Ingelheim: personal fees, Bioeq/Formycon: personal fees and non-financial support, CenterVue: non-financial support, Ellex: non-financial support, Roche/Genetech: Grant and personal fees, Geuder: personal fees, Grayburg Vision: personal fees and non-financial support, Heidelberg Engineering: Grant, per-sonal fees and non-financial support, Kanghong: personal fees and non-financial sup-port, LinBioscience: personal fees and non-financial support, NightStarX: non-financial support, Novartis: Grant, personal fees and non-financial support, Optos: non-financial support, Pixium Vision: Grant, personal fees and non-financial support, Oxurion: personal fees and non-financial support, Stealth BioTherapeutics: personal fees and non-financial support, Zeiss Meditec: Grant and non-financial support; Schaefer C: no additional disclosures; Finger RP: Novartis: Grant, personal fees and non-financial support, Bayer: personal fees, Roche/Genetech: personal fees, Alimera: personal fees, Santhera: personal fees, Ellex: personal fees, Opthea: personal fees, Inositec: personal fees, CenterVue: non-financial support, Heidelberg Engineering: non-financial support, Optos: non-financial support, Zeiss Meditec: non-financial support; Schahab N: no additional disclosures; the funding organization had no role in design and conduct of the study, collection, management, analyses, and interpretation of the data, preparation, review, or approval of the manuscript and decision to submit the manuscript for publication. Data used in this study will be provided on reasonable request. The corresponding author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analyses.
